Insulin-regulated hepatic gluconeogenesis through FOXO1–PGC-1α interaction
The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
Hepatic gluconeogenesis is absolutely required for survival during prolonged fasting or starvation, but is inappropriately activated in diabetes mellitus. Glucocorticoids and glucagon have strong gluconeogenic actions on the liver. In contrast, insulin suppresses hepatic gluconeogenesis. Two components known to have important physiological roles in this process are the forkhead transcription factor FOXO1 (also known as FKHR) and peroxisome proliferative activated receptor-gamma co-activator 1 (PGC-1alpha; also known as PPARGC1), a transcriptional co-activator; whether and how these factors collaborate has not been clear. Using wild-type and mutant alleles of FOXO1, here we show that PGC-1alpha binds and co-activates FOXO1 in a manner inhibited by Akt-mediated phosphorylation. Furthermore, FOXO1 function is required for the robust activation of gluconeogenic gene expression in hepatic cells and in mouse liver by PGC-1alpha. Insulin suppresses gluconeogenesis stimulated by PGC-1alpha but co-expression of a mutant allele of FOXO1 insensitive to insulin completely reverses this suppression in hepatocytes or transgenic mice. We conclude that FOXO1 and PGC-1alpha interact in the execution of a programme of powerful, insulin-regulated gluconeogenesis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“PGC-1α is a key regulator of mitochondrial biogenesis and respiration [27] that plays a critical role in the control of metabolism and energy homeostasis [28-30].”
From PGC-1α in aging and anti-aging interventions (2009) · cites this paper as [30]
In the citing paper
“hepatic gluconeogenesis was suppressed, as witnessed by decreased expression of the FoxO1-regulated genes phosphoenolpyruvate carboxykinase (Pepck) and glucose-6-phosphatase (G6P) [72].”
From Physiologic functions of PP2A: Lessons from genetically modified mice (2019) · cites this paper as [72]
Citations
Cites
Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor
Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. C., Blenis, J., & Greenberg, M. E. (1999) · Cell · doi:10.1016/s0092-8674(00)80595-4 · Cited by 5,594
A Cold-Inducible Coactivator of Nuclear Receptors Linked to Adaptive Thermogenesis
Puigserver, P., Wu, Z., Park, C. W., Graves, R., Wright, M., & Spiegelman, B. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81410-5 · Cited by 3,864
Self-citationControl of hepatic gluconeogenesis through the transcriptional coactivator PGC-1
Yoon, J. C., Puigserver, P., Chen, G., Donovan, J., Wu, Z., Rhee, J., Adelmant, G., Stafford, J., Kahn, C. R., Granner, D. K., et al. (2001) · Nature · doi:10.1038/35093050 · Cited by 1,821
Self-citationCREB regulates hepatic gluconeogenesis through the coactivator PGC-1
Herzig, S., Long, F., Jhala, U. S., Hedrick, S., Quinn, R., Bauer, A., Rudolph, D., Schutz, G., Yoon, C., Puigserver, P., et al. (2001) · Nature · doi:10.1038/35093131 · Cited by 1,440
Self-citationREGULATION OF PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP) GENE EXPRESSION
Hanson, R. W., & Reshef, L. (1997) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.66.1.581 · Cited by 729 · cited 1×
“In contrast, insulin suppresses hepatic gluconeogenesi”
The Forkhead Transcription Factor Foxo1 Regulates Adipocyte Differentiation
Nakae, J., Kitamura, T., Kitamura, Y., Biggs, W. H., Arden, K. C., & Accili, D. (2003) · Developmental Cell · doi:10.1016/s1534-5807(02)00401-x · Cited by 727
Self-citationPhosphorylation of the Transcription Factor Forkhead Family Member FKHR by Protein Kinase B
Rena, G., Guo, S., Cichy, S. C., Unterman, T. G., & Cohen, P. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.24.17179 · Cited by 714
Nakae, J., Kitamura, T., Silver, D. L., & Accili, D. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12876 · Cited by 652
Self-citationNakae, J., Kitamura, T., Silver, D. L., & Accili, D. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200112876 · Cited by 652
Self-citationNakae, J., Biggs, W. H., Kitamura, T., Cavenee, W. K., Wright, C. V. E., Arden, K. C., & Accili, D. (2002) · Nature Genetics · doi:10.1038/ng890 · Cited by 616
Self-citation
Cited by
Items 801–900 of 1,000
Alonge, K. M., Meares, G. P., & Hillgartner, F. B. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.762922 · Cited by 34
DDB1-Mediated CRY1 Degradation Promotes FOXO1-Driven Gluconeogenesis in Liver
Tong, X., Zhang, D., Charney, N., Jin, E., VanDommelen, K., Stamper, K., Gupta, N., Saldate, J. J., & Yin, L. (2017) · Diabetes · doi:10.2337/db16-1600 · Cited by 33
Takai, A., Dang, H. T., Oishi, N., Khatib, S. A., Martin, S. P., Dominguez, D. A., Luo, J., Bagni, R., Wu, X., Powell, K., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3015 · Cited by 32
The Tumor Suppressor Roles of MYBBP1A, a Major Contributor to Metabolism Plasticity and Stemness
Felipe‐Abrio, B., & Carnero, A. (2020) · Cancers · doi:10.3390/cancers12010254 · Cited by 37
Avilkina, V., Chauveau, C., & Mhenni, O. G. (2021) · Bone · doi:10.1016/j.bone.2021.116232 · Cited by 34
Insulin-Responsive Transcription Factors
Thiel, G., Guethlein, L. A., & Rößler, O. G. (2021) · Biomolecules · doi:10.3390/biom11121886 · Cited by 38
“Accordingly, insulin administration decreased binding of PGC-1α and FoxO1 to the gluconeogenic genes encoding PEPCK and G6Pase in vivo [53].”
InfluentialPasqua, L. G. D., Cagna, M., Berardo, C., Vairetti, M., & Ferrigno, A. (2022) · Biomedicines · doi:10.3390/biomedicines10010194 · Cited by 37
“SREPB-1c is also involved in the inhibition of PPARγ coactivator 1α (PGC-1α), which activates phosphoenolpyruvate carboxykinase (PEPCK), a rate-limiting enzyme that promotes gluconeogenesis [183].”
BackgroundKrzysztoń-Russjan, J., Zielonka, D., Jackiewicz, J., Kuśmirek, S., Bubko, I., Klimberg, A., Marcinkowski, T., & Anuszewska, E. (2012) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-012-9479-3 · Cited by 34
“It participates in energy homeostasis, adaptive thermogenesis, β-oxidation of fatty acids, and glucose metabolism by regulating the expression of mitochondrial OXPHOS genes and endogenous antioxidants (Puigserver et al. 2003).”
BackgroundWang, Y., Chen, C., Lin, S., Chuang, Y., Sheu, W. H., & Tung, K. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.12.016 · Cited by 33
Insulin's expanding control of forkheads
Czech, M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2135308100 · Cited by 35
Sadana, P., Zhang, Y., Song, S., Cook, G. A., Elam, M. B., & Park, E. A. (2006) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2006.11.012 · Cited by 32
Zarfeshani, A., Ngo, S., & Sheppard, A. M. (2014) · Clinical Epigenetics · doi:10.1186/1868-7083-6-27 · Cited by 32
“PPARGC1A and forkhead transcription factor (FOXO1) play important roles in glucose metabolism [16], and nuclear accumulation of the latter also stimulates TG synthesis [17].”
BackgroundYang, T., Liu, T., Cao, C., & Xu, S. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27206 · Cited by 32
Yang, C., Shiau, M., Lai, Y.-R., Ho, K.-T., Hsiao, C., Chen, C., Lo, Y., & Chang, Y.-H. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/6923187 · Cited by 34
Yarushkin, A. A., Качайло, Е. М., & Pustylnyak, V. O. (2012) · British Journal of Pharmacology · doi:10.1111/bph.12090 · Cited by 34
“1928 British Journal of Pharmacology (2013) 168 1923–1932 metabolism in the adult liver, especially during fasting (Puigserver et al., 2003; Accili and Arden, 2004).”
BackgroundKim, Y. D., Kim, S., Hwang, S., Choi, H.-S., Bae, J., Song, D., & Im, S. (2014) · Diabetes · doi:10.2337/db13-1368 · Cited by 35
Mitochondria and diabetes mellitus: untangling a conflictive relationship?
Schiff, M., Loublier, S., Coulibaly, A., Bénit, P., Ogier de Baulny, H., & Rustin, P. (2009) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-009-1263-0 · Cited by 34
“Peroxisome proliferator-activated receptor g co-activator 1a (PGC1a) is the main stimulant of hepatic gluconeogenesis (Herzig et al. 2001; Saltiel and Kahn 2001; Yoon et al. 2001) and is inhibited by insulin (Li et al. 2007; Puigserver et al. 2003; Yoon et al. 2001).”
BackgroundTavares, C. D. J., Aigner, S., Sharabi, K., Sathe, S., Mutlu, B., Yeo, G. W.-M., & Puigserver, P. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2000643117 · Cited by 33
Self-citationChen, T., Dalton, G. D., Oh, S., Maeso‐Díaz, R., Du, K., Meyers, R. A., Guy, C. D., Abdelmalek, M. F., Henao, R., Guarnieri, P., et al. (2022) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2022.12.008 · Cited by 35
Reitzner, S. M., Emanuelsson, E. B., Arif, M., Kaczkowski, B., Kwon, A. T.-J., Mardinoğlu, A., Arner, E., Chapman, M., & Sundberg, C. J. (2023) · Molecular Metabolism · doi:10.1016/j.molmet.2023.101857 · Cited by 44
Okamoto, T., Kanemoto, N., Ban, T., Sudo, T., Nagano, K., & Niki, I. (2009) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2009.09.015 · Cited by 31
Arpiainen, S., Järvenpää, S.-M., Manninen, A., Viitala, P., Lang, M. A., Pelkonen, O., & Hakkola, J. (2008) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2008.06.001 · Cited by 33
Chakravarty, K., & Hanson, R. W. (2008) · Nutrition Reviews · doi:10.1111/j.1753-4887.2007.tb00328.x · Cited by 32
Nachar, A., Vallerand, D., Musallam, L., Lavoie, L., Badawi, A. F., Arnason, J. T., & Haddad, P. S. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/189819 · Cited by 33
“The phosphorylated transcription factors are then expelled from the nucleus, the expression of enzymes is inhibited, and the production of glucose in the liver is eventually reduced [13, 14].”
BackgroundRyan, K. M., Patterson, I., & McLoughlin, D. M. (2018) · Psychological Medicine · doi:10.1017/s0033291718002556 · Cited by 33
“…transcription factors, e.g. PPARs (Puigserver et al., 1998; Vega et al., 2000), thyroid hormone receptors (Puigserver et al., 1998), glucocorticoid receptors (Jang et al., 2007), oestrogen-related receptors (Takacs et al., 2013) and the forkhead O-box (FOXO) family (Puigserver et al., 2003).”
BackgroundXue, J., Shi, Y., Li, C., & Song, H. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27933 · Cited by 31
Tankyrase inhibition ameliorates lipid disorder via suppression of PGC-1α PARylation in db/db mice
Wang, H., Kuusela, S., Rinnankoski‐Tuikka, R., Dumont, V., Bouslama, R., Ramadan, U. A., Waaler, J., Linden, A.-M., Chi, N., Krauss, S. J. K., et al. (2020) · International Journal of Obesity · doi:10.1038/s41366-020-0573-z · Cited by 32
The Genetics of Diabetes: What We Can Learn from Drosophila
Liguori, F., Mascolo, E., & Vernì, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222011295 · Cited by 36
Lactational delivery of Triclosan promotes non-alcoholic fatty liver disease in newborn mice
Weber, A. A., Yang, X., Mennillo, E., Ding, J., Watrous, J. D., Jain, M., Chen, S., Karin, M., & Tukey, R. H. (2022) · Nature Communications · doi:10.1038/s41467-022-31947-4 · Cited by 32
Liang, D., Zhang, Y., Han, J., Wang, W., Liu, Y., Li, J.-F., & Jiang, X. (2015) · Endocrine journal · doi:10.1507/endocrj.ej15-0186 · Cited by 27
Transcriptional control of circadian metabolic rhythms in the liver
Li, S., & Lin, J. D. (2015) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12520 · Cited by 33
Oliveri, L. M., Davio, C. A., Batlle, A. M. D. C., & Gerez, E. N. (2012) · Biochemical Journal · doi:10.1042/bj20111005 · Cited by 31
Energetic cell sensors: a key to metabolic homeostasis
Naïmi, M., Arous, C., & OBBERGHEN, E. V. (2009) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2009.09.003 · Cited by 33
Oriente, F., Iovino, S., Cabaro, S., Cassese, A., Longobardi, E., Miele, C., Ungaro, P., Formisano, P., Blasi, F., & Bèguinot, F. (2010) · Diabetes · doi:10.2337/db10-0860 · Cited by 30
Self-citationRetractedSeenappa, V., Joshi, M. B., & Satyamoorthy, K. (2019) · Current Molecular Medicine · doi:10.2174/1566524019666190404155801 · Cited by 41
Park, S., Lee, D., Kim, D., Lee, M., In, G., Han, S.-T., Kim, S. W., Lee, M. H., Kim, O., & Lee, J. (2019) · Journal of Ginseng Research · doi:10.1016/j.jgr.2019.12.004 · Cited by 31
The roles of sirtuins in ferroptosis
Zeng, J., Guo, J., Huang, S., Cheng, Y., Luo, F., Xu, X., Chen, R., Ma, G., & Wang, Y. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1131201 · Cited by 34
“In addition, studies showed that, by the inhibition of the activity of FOXO1, insulin suppresses gluconeogenesis in the liver and decreases blood glucose, thereby alleviating diabetes (Puigserver et al., 2003; Semova et al., 2022).”
BackgroundFan, Y., Guo, Y., Hamblin, M., Chang, L., Zhang, J., & Chen, Y. E. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.232918 · Cited by 42
Redox Remodeling Is Pivotal in Murine Diaphragm Muscle Adaptation to Chronic Sustained Hypoxia
Lewis, P., Sheehan, D., Soares, R. F., Coelho, A. V., & O’Halloran, K. D. (2016) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2015-0272oc · Cited by 32
Peripheral Adrenoceptors: The Impetus Behind Glucose Dysregulation and Insulin Resistance
Boyda, H. N., Procyshyn, R. M., Pang, C. C. Y., & Barr, A. M. (2013) · Journal of Neuroendocrinology · doi:10.1111/jne.12002 · Cited by 34
del Pozo, C. H., Calvo, R. M., Vesperinas, G., Gómez‐Ambrosi, J., Frühbeck, G., Rubio, M. Á., & Obregón, M.-J. (2010) · Obesity Surgery · doi:10.1007/s11695-010-0246-4 · Cited by 36
Liu, H., Collins, Q. F., Moukdar, F., Zhuo, D., Han, J., Hong, T., Collins, S., & Cao, W. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801033200 · Cited by 31
PGC-1α Regulates Translocated in Liposarcoma Activity: Role in Oxidative Stress Gene Expression
Sánchez‐Ramos, C., Tiérrez, A., Fabregat‐Andrés, Ó., Wild, B., Sánchez‐Cabo, F., Arduini, A., Dopazo, A., & Monsalve, M. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3643 · Cited by 34
Effects of hyperglycemia and aging on nuclear sirtuins and DNA damage of mouse hepatocytes
Ghiraldini, F. G., Crispim, A. C. V., & Mello, M. L. S. (2013) · Molecular Biology of the Cell · doi:10.1091/mbc.e13-04-0186 · Cited by 33
Tyrosine kinase inhibitors as novel drugs for the treatment of diabetes
Prada, P. O., & Saad, M. J. A. (2013) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2013.802768 · Cited by 32
“Activated Akt also decreases the expression of gluconeogenic genes by preventing FoxO1 nuclear localization and transcriptional activity [10,11].”
BackgroundParvaiz, F., Manzoor, S., Iqbal, J., Sarkar-Dutta, M., Imran, M., & Waris, G. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i43.12361 · Cited by 33
Past and current perspective on new therapeutic targets for Type-II diabetes
Patil, P. D., Mahajan, U. B., Patil, K. R., Chaudhari, S. T., Patil, C. R., Agrawal, Y. O., Ojha, S. K., & Goyal, S. N. (2017) · Drug Design Development and Therapy · doi:10.2147/dddt.s133453 · Cited by 33
Felder, T. K., Hahne, P., Soyal, S. M., Miller, K., Höffinger, H., Oberkofler, H., Krempler, F., & Patsch, W. (2010) · International Journal of Obesity · doi:10.1038/ijo.2010.7 · Cited by 33
Glucokinase as a Glucose Sensor: Past, Present and Future
Magnuson, M. A., & Matschinsky, F. M. (2004) · KARGER eBooks · doi:10.1159/000079003 · Cited by 33
Oberkofler, H., Schraml, E., Krempler, F., & Patsch, W. (2004) · Biochemical Journal · doi:10.1042/bj20040173 · Cited by 30
Pauli, L. S. S., Ropelle, E. C. C., Souza, C. T., Cintra, D. E., Silva, A. S. R., Rodrigues, B. D. A., de Moura, L. P., Marinho, R., de Oliveira, V., Katashima, C. K., et al. (2014) · The Journal of Physiology · doi:10.1113/jphysiol.2013.264002 · Cited by 29
“In loss- and gain-of-function experiments in mice, FoxO1 has been associated with the hepatic glucose production (Pagliassotti et al. 2002; Puigserver et al. 2003).”
BackgroundInfluentialMechanisms of transcription factor acetylation and consequences in hearts
Thiagarajan, D., Vedantham, S., Ananthakrishnan, R., Schmidt, A. M., & Ramasamy, R. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.08.011 · Cited by 31
Xiao, F., Guo, Y., Deng, J., Yuan, F., Xiao, Y., Hui, L., Li, Y., Hu, Z., Zhou, Y., Li, K., et al. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.12.003 · Cited by 29
FoxO1 is a critical regulator of hepatocyte lipid deposition in chronic stress mice
Liu, Y., Wei, P., Chen, J., Su, W., Yan, W., Wang, Y., & Jiang, C. (2019) · PeerJ · doi:10.7717/peerj.7668 · Cited by 28
“Active nuclear FOXO1 also binds the transcriptional coactivator peroxisome proliferative activated receptor-γ coactivator 1-a (PGC1a) to coordinate a gluconeogenic transcriptional program involving increased expression of G6Pase and cytosolic phosphoenolpyruvate carboxykinase (Pck1) (Puigserver et al., 2003; Nakae et…”
BackgroundZhang, J., Feng, F., & Zhao, M. (2021) · Nutrients · doi:10.3390/nu13051427 · Cited by 31
Curcumin attenuates isoniazid‐induced hepatotoxicity by upregulating the SIRT1/PGC‐1α/NRF1 pathway
Li, Y., Luo, W.-W., Cheng, X., Xiang, H., He, B., Zhang, Q., & Wen-xing, P. (2022) · Journal of Applied Toxicology · doi:10.1002/jat.4288 · Cited by 32
“…to synergically activate a variety of oxidative stress-related nuclear receptors and transcription factors, including nuclear respiratory factor 1 (NRF1), nuclear respiratory factor 2 (NRF2) (St-Pierre et al., 2006; Wu et al., 1999), and forkhead box protein O1 (FoxO1) (Puigserver et al., 2003).”
BackgroundShin, D.-J., & Osborne, T. F. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710452200 · Cited by 32
Molecular control of circadian metabolic rhythms
Li, S., & Lin, J. D. (2009) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00467.2009 · Cited by 33
Wesolowski, S. R., Sekar, S. M., Lavezzi, J. R., O'Meara, M. C., Brown, L. D., Hay, W. W., & Rozance, P. J. (2012) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00331.2012 · Cited by 30
“ERRA expression was further increased in the HG INS group, however, which could be due to insulindependent effects on stimulating hepatic oxidative metabolism or insulin’s effects on regulating PGC-1 function separate from its effects on PGC1A expression (15, 21, 30, 41).”
BackgroundSalgado, M. C. D. O., Metón, I., Egea, M., & Baanante, I. V. (2004) · Journal of Molecular Endocrinology · doi:10.1677/jme.1.01552 · Cited by 33
“After incubation at 37 C (usually 20 min to 1 h), the reaction was stopped by addition of 0·5 ml 0·5 M Na2CO3, and the intensity of the yellow colour was determined by its optical density at 420 nm. The expression plasmids encoding rat HNF-4 (pcDNA3.HNF4; Bartoov-Shifman et al. 2002), mouse PGC-1 (pSV2-PGC1; Puigserve…”
MethodThe hepatic FOXQ1 transcription factor regulates glucose metabolism in mice
Cui, Y., Qiao, A., Jiao, T., Zhang, H., Xue, Y., Zou, Y., Cui, A., Fang, F., & Chang, Y. (2016) · Diabetologia · doi:10.1007/s00125-016-4043-z · Cited by 31
Regulation of Hepatic Glucose Metabolism by FoxO Proteins, an Integrated Approach
Unterman, T. G. (2017) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2017.10.005 · Cited by 30
Han, X., Zhang, L., Ding, L., Shi, H.-H., Xue, C., Zhang, T., & Wang, Y. (2019) · Food & Function · doi:10.1039/c9fo01147a · Cited by 28
Yaman, D., Takmaz, T., Yüksel, N., Dinçer, S. A., & Şahin, F. İ. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-05994-3 · Cited by 29
Transcriptional activation of SHP by PPAR-γ in liver
Kim, H., Koh, Y.-K., Kim, T. H., Kwon, S., Im, S., Choi, H.-S., Kim, K., & Ahn, Y. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.05.171 · Cited by 29
“oxisome proliferator-activated receptor c coactivator 1 (PGC-1) are known to contribute to this transcriptional regulation [1–7].”
BackgroundSirtuins and SIRT6 in Carcinogenesis and in Diet
Teixeira, M. C., Sánchez‐López, E., Espina, M., García, M. L., Durazzo, A., Lucarini, M., Novellino, E., Souto, S. B., Santini, A., & Souto, E. B. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194945 · Cited by 29
Li, L., Zhao, H., Chen, B., Fan, Z., Li, N., Yue, J., & Ye, Q. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-02170-5 · Cited by 28
RetractedKachaylo, E., Yarushkin, A. A., & Pustylnyak, V. O. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.01.007 · Cited by 30
Mapping MKP-3/FOXO1 Interaction and Evaluating the Effect on Gluconeogenesis
Jiao, P., Feng, B., & Xu, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041168 · Cited by 30
Han, S., Zhang, T., Kusumanchi, P., Huda, N., Jiang, Y., Yang, Z., & Liangpunsakul, S. (2020) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2020.0166 · Cited by 27
Hyttinen, J. M. T., Błasiak, J., Tavi, P., & Kaarniranta, K. (2021) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2021.1991913 · Cited by 30
Multi-target regulation of intestinal microbiota by berberine to improve type 2 diabetes mellitus
He, Q., Dong, H., Guo, Y., Gong, M., Xia, Q., Lu, F., & Wang, D. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1074348 · Cited by 27
“FOXO1 function is required for the robust activation of gluconeogenic gene expression in hepatic cells to promote hyperglycemia (50).”
BackgroundSelf-citationParvaiz, F., Manzoor, S., Iqbal, J., McRae, S., Javed, F., Ahmed, Q. L., & Waris, G. (2013) · Archives of Virology · doi:10.1007/s00705-013-1892-3 · Cited by 29
Bernsmeier, C., Calabrese, D., Heim, M. H., & Duong, F. H. T. (2013) · Journal of Viral Hepatitis · doi:10.1111/jvh.12208 · Cited by 26
Mukherjee, S., Basar, M. A., Davis, C. P., & Duttaroy, A. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00216 · Cited by 27
“In the absence of Insulin, PGC-1 expression is elevated in liver and gluconeogenesis is initiated (Puigserver et al., 2003).”
BackgroundCámara, Y., Mampel, T., Armengol, J., Villarroya, F., & Dejean, L. M. (2009) · Cellular Physiology and Biochemistry · doi:10.1159/000233249 · Cited by 30
Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD) and Viral Hepatitis
Wang, X., & Xie, Q. (2021) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2021.00200 · Cited by 37
Crosstalk between bone and other organs
Yuan, W., & Song, C. (2022) · Medical Review · doi:10.1515/mr-2022-0018 · Cited by 28
Yang, Y.-N., Zhang, M.-Q., Yu, F.-L., Han, B., Bao, M.-Y., Yan-He, Yan-he, & Zhang, Y. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115717 · Cited by 26
Insulin-Inducible SMILE Inhibits Hepatic Gluconeogenesis
Lee, J.-M., Seo, W., Han, H.-S., Oh, K., Lee, Y. S., Kim, D., Choi, S., Choi, B. H., Harris, R. A., Lee, C., et al. (2015) · Diabetes · doi:10.2337/db15-0249 · Cited by 26
IRS2 and PTP1B: Two opposite modulators of hepatic insulin signalling
Valverde, Á. M., & González‐Rodríguez, Á. (2011) · Archives of Physiology and Biochemistry · doi:10.3109/13813455.2011.557386 · Cited by 34
“As stated above, Foxo1 is the molecular link between Akt phosphorylation and gluconeogenic gene expression (Nakae et al., 2001; Puigserver et al., 2003).”
BackgroundLi, T., Ma, H., Park, Y. J., Lee, Y., Strom, S. C., Moore, D. D., & Chiang, J. Y. L. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.05.004 · Cited by 25
“Increased hepatic expression of FoxO1 is associated with elevated hepatic glucose production and fatty accumulation in mice [20,21].”
BackgroundYubero, P., Hondares, E., Carmona, M. C., Rosell, M., Gonzalez, F. J., Iglesias, R., Giralt, M., & Villarroya, F. (2004) · Endocrinology · doi:10.1210/en.2004-0099 · Cited by 28
Bi, Y., Shi, X., Zhu, J., Guan, X., Garbacz, W. G., Huang, Y., Gao, L. P., Yan, J., Xu, M., Ren, S., et al. (2018) · Molecular and Cellular Biology · doi:10.1128/mcb.00654-17 · Cited by 29
Varghese, J., James, J., Vaulont, S., McKie, A. T., & Jacob, M. (2018) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2018.05.022 · Cited by 25
Altered hepatic glucose homeostasis in AnxA6-KO mice fed a high-fat diet
Cairns, R. F., Fischer, A. W., Blanco‐Muñoz, P., Álvarez-Guaita, A., Meneses‐Salas, E., Egert, A., Buechler, C., Hoy, A. J., Heeren, J., Enrich, C., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0201310 · Cited by 26
Wang, Y., Guan, Y., Xue, L., Liu, J., Yang, Z., Nie, C., Yan, Y., Liu, S., Sun, J., Fan, M., et al. (2021) · Food & Function · doi:10.1039/d0fo02163f · Cited by 26
FOXO in aging: Did evolutionary diversification of FOXO function distract it from prolonging life?
Schaible, R., & Sussman, M. (2013) · BioEssays · doi:10.1002/bies.201300078 · Cited by 29
Effects of sodium salicylate on glucose kinetics and insulin signaling in postpartum dairy cows
Montgomery, S. R., Mamedova, L. K., Zachut, M., Kra, G., Häussler, S., Vaughn, M. A., Gonzalez, J. M., & Bradford, B. J. (2018) · Journal of Dairy Science · doi:10.3168/jds.2018-15312 · Cited by 25
Plasma miR-193b-3p Is Elevated in Type 2 Diabetes and Could Impair Glucose Metabolism
Hu, H., Zhao, M., Li, Z., Nie, H., He, J., Cheng, Z., Yuan, J., Guo, H., Zhang, X., Yang, H., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.814347 · Cited by 29
“Aberrant expression of these miRNAs can result in an over or under expression of key enzymes, such as phosphoenolpyruvate carboxykinase (PEPCK) and glucose-6phosphatase (G6PC), contributing to the etiology of diabetes (8).”
BackgroundResultInfluentialThe role of FOXO1-mediated autophagy in the regulation of bone formation
Jiang, Y., Luo, W., Zhou, F., Gong, P., & Xiong, Y. (2022) · Cell Cycle · doi:10.1080/15384101.2022.2155443 · Cited by 24
Acute suppression of apo B secretion by insulin occurs independently of MTP
Sparks, J. D., Chamberlain, J. M., O’Dell, C., Khatun, I., Hussain, M. M., & Sparks, C. E. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.02.028 · Cited by 28
Foxn1 in Skin Development, Homeostasis and Wound Healing
Wiśniewska, J., Kopcewicz, M. M., Walendzik, K., & Gawrońska‐Kozak, B. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19071956 · Cited by 27
Xie, X., Yan, D., Li, H., Zhu, Q., Li, J., Fang, Y., Cheung, C. W., Irwin, M. G., Xia, Z., & Lian, Q. (2018) · Journal of Diabetes Research · doi:10.1155/2018/6254340 · Cited by 29
“After the binding of insulin to insulin receptor (IR), Akt is activated, subsequently phosphorylating and excluding FoxO1 proteins from the nucleus to the cytoplasm, thus dampening its effects to promote glucose production [15], both in isolated hepatocytes [16] and transgenic mouse models [17].”
BackgroundCintra, D. E., Ropelle, E. R., & Pauli, J. R. (2007) · Revista de Neurología · doi:10.33588/rn.4511.2006612 · Cited by 36
Insig: a significant integrator of nutrient and hormonal signals
Attie, A. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421450 · Cited by 24
Hypoglycemic effects and associated mechanisms of resveratrol and related stilbenes in diet
Peng, J., Lu, C., Luo, Y., Su, X., Li, S., & Ho, C. (2024) · Food & Function · doi:10.1039/d3fo04761j · Cited by 26
Wang, Y., Tian, X., Wang, Z., Liu, D., Zhao, X., Sun, X., Tu, Z., Li, Z., Zhao, Y., Zheng, S., et al. (2024) · Clinical and Translational Medicine · doi:10.1002/ctm2.1801 · Cited by 28
Insights into Transcriptional Regulation of Hepatic Glucose Production
Anyamaneeratch, K., Rojvirat, P., Sukjoi, W., & Jitrapakdee, S. (2015) · International review of cytology · doi:10.1016/bs.ircmb.2015.05.004 · Cited by 28
“PGC-1a stimulates gluconeogenesis by coactivating the HNF4a, GR (Yoon et al., 2001; Herzig et al., 2001; Rhee et al., 2003; Boustead et al., 2003; Schilling et al., 2006) or partly with FoxO1 (Puigserver et al., 2003) transcription factors.”
BackgroundFoxO genes are dispensable during gastrulation but required for late embryogenesis in Xenopus laevis
Schuff, M., Siegel, D., Bardine, N., Oswald, F., Donow, C., & Knöchel, W. (2009) · Developmental Biology · doi:10.1016/j.ydbio.2009.10.036 · Cited by 24
“…genes involved in DNA damage repair (Gadd45a) (Tran et al., 2002), cell metabolism (glucose-6-phosphatase, phosphoenolpyruvate carboxykinase) (Puigserver et al., 2003; Hall et al., 2000), cell cycle arrest (p21CIP1, p27kip1) (Rathbone et al., 2008) and apoptosis (FasL, Bim) (Stahl et al.,…”
Background
Metadata
- Authors
- Puigserver, P., Rhee, J., Donovan, J., Walkey, C. J., Yoon, J. C., Oriente, F., Kitamura, Y., Altomonte, J., Dong, H., Accili, D., & Spiegelman, B. M.
- Affiliations
- Harvard University (US)
- Columbia University (US)
- Icahn School of Medicine at Mount Sinai (US)
- Corresponding author
- Spiegelman, Bruce M.
- ORCID
- Venue
- Nature
- Published
- 2003-05-18
- Volume
- 423
- Issue
- 6939
- Pages
- 550-555
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1583767403
- Cited by
- 1,487
- References
- 22
- Citations by year
- 2026: 31 · 2025: 45 · 2024: 46 · 2023: 53 · 2022: 62 · 2021: 67 · 2020: 71 · 2019: 61 · 2018: 86 · 2017: 76 · 2016: 59 · 2015: 75 · 2014: 71 · 2013: 68 · 2012: 81
- FWCI
- 21.04
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Taiho Pharmaceutical
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › FOXO transcription factor regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fibroblast Growth Factor Research
- Keywords
- hepatic gluconeogenesis, insulin signaling, FOXO1, PGC-1α, transcriptional coactivation, Akt phosphorylation, fasting, diabetes mellitus, glucocorticoids, glucagon, gluconeogenic gene expression, hepatocytes, forkhead transcription factor
- MeSH terms
- Forkhead Box Protein O1, Animals, Cells, Cultured, DNA-Binding Proteins, Gene Expression Regulation, Gluconeogenesis, Insulin, Liver, Precipitin Tests, Protein Binding, RNA, Messenger, Transcription Factors, Hepatocytes, Mice, Forkhead Transcription Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.